FDA Investigator Lavender M Huskey

Lavender M Huskey has inspections in 2 countries as of 08 Sep 2023. Lavender M Huskey has collaborated with a combinined 2547 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
08 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Italy
Alan P Kurtzberg, Alecia L Marson, Alejandro Rodriguez, Alexandra B Pitkin, Alicia A Armijo, Alvaro G Dominguez, Andrea J Schmidt, Andrew M Kolenc, Angela Shepas, Antonetta M Colacchio, Arie C Menachem, Ashley M Caputo, Betty K Baxter, Bichsa T Tran, Brandon K Lawson, Brent W Higgs, Brittany R Laymon, Bruce W Benware, Carla R Hinz, Carolyn J Cook, Carrie E Jolly, Carterm, Christin L Torres, Christine L Williams, Christopher J Freebairn, Daniel Pst Laurent, Daniel T Smith, David A Gonzalez, Debra L Curtis, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donald R Hawn, Duc Minh H Nguyen, Edith M Gonzalez, Elisa J Beard, Eric R Holm, Eric S Myskowski, Felix J Marrero, Frank L Cordova, Garrad R Poole, Gary C Pecic, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Grace E Mcnally, Hanna L Potter, Harry A Wilson, Holly L Miller, Hung H Do, MS, Isabel Y Espinosa, Isaiah D Isakson, Jacob W Reynolds, James D Romero, Jamie L Dion, Jamie L Port, Janet Pulver, Janete A Oliveira, Janice L Straight, Jeanne J Thai, Jennifer A Baker, Jennifer A Robinson, Jennifer L Wolfe, Jennifer M Pouget, Jennifer R Mathern, Jessica M Ector, John A Daubenspeck, Jonathan R Campos, Kathleen S Tormey, Kathryn M Mogen, Keith C Littrell, Kelly D Moore, Khumo A Phake, Kimberley A Hoefen, Kristen E Szenderski, Lakecha N Lewis, Larisa E Pavlick, Larry Gehring, Laura A Munsterman, Laura B Kennedy, Laura L Van Wagenen, Linda F Murphy, Linda M Cheny, Manuel A Moreno, Marc A Jackson, Jr, Marie Bbuen Bigornia, Marie Gbuen Bigornia, Marion W Nadeau, Marquez D Berrianvalle, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Johnson, Matthew A Kozler, Matthew R Dionne, Meaghan M Rabideau, Mendoza O Wallace, Michael D Garcia, Michael E Maselli, Michael L Zimmerman, Michael R Goga, Michelle D Motsinger, Narahi J Alvarez Alcazar, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Nicholas Fragedakis, Nicole J Clausen, Oluwaseyi Ojinni, Patricia A Brown, Patricia A Maestas, Paul J Teitell, Paul Z Balcer, Philip E Ake, Rafael H Ortiz, Randy V Bong, Richard T Jensen, Rumany C Penn, PharmD, Ruth A Williams, Samantha E Rafferty, Sean P Desbrow, Sheila Alaghemand, Shererk, Siobhan G Taylor, Solomon G Williams, State Agency, Steve P Yost, Steven O Gauthier, Tamara L Setzer, Tawny L Colling, Tenzin Jangchup, Thai T Duong, Thea C Grome, Theressa B Smith, Thomas V Anderson, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vanessa R Muller, Virgilio F Pacio, CSO, William A Lanier, William D Boden, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Lavender M Huskey's Documents

Publish Date Document Type Title
August, 2020 FDA 483 BioCorRx Inc - Form 483, 2020-08-14
October, 2017 FDA 483 Deseret Laboratories, Inc. - Form 483, 2017-10-26
December, 2019 FDA 483 Patel, Vikas V. - Form 483, 2019-12-17
February, 2017 FDA 483 Davis Ventures, Inc - Form 483, 2017-02-23
April, 2017 FDA 483 Green Chile Concepts, LLC - Form 483, 2017-04-28
December, 2018 FDA 483 Organic India USA, LLC - Form 483, 2018-12-11
April, 2017 EIR Green Chile Concepts, LLC - EIR, 2017-04-28
February, 2020 FDA 483 Spectrum Pharmaceuticals, Inc. - Form 483, 2020-02-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more